DK0676398T3 - Heterocykliske forbindelser, som har antidiabetisk aktivitet, deres fremstilling og deres anvendelse - Google Patents

Heterocykliske forbindelser, som har antidiabetisk aktivitet, deres fremstilling og deres anvendelse

Info

Publication number: DK0676398T3
Authority: DK; Denmark
Prior art keywords: group; formula; heterocyclic compounds; carboxylic acyl; atom
Prior art date: 1994-04-11

Application number

DK95302409T

Other languages

English (en)

Inventor

Takashi

Koichi

Takao

Hiroaki

Toshihiko

Hiroyoshi

Minoru

Kunio

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-11

Filing date

1995-04-11

Publication date

2001-12-10

1995-04-11 Application filed by Sankyo Co filed Critical Sankyo Co

2001-12-10 Application granted granted Critical

2001-12-10 Publication of DK0676398T3 publication Critical patent/DK0676398T3/da

Links

230000003178 anti-diabetic effect Effects 0.000 title abstract 2
150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
125000003118 aryl group Chemical group 0.000 abstract 3
125000001589 carboacyl group Chemical group 0.000 abstract 3
125000001931 aliphatic group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000003710 aryl alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000002218 hypoglycaemic effect Effects 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heat Sensitive Colour Forming Recording (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)

DK95302409T 1994-04-11 1995-04-11 Heterocykliske forbindelser, som har antidiabetisk aktivitet, deres fremstilling og deres anvendelse DK0676398T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP7208394		1994-04-11

Publications (1)

Publication Number	Publication Date
DK0676398T3 true DK0676398T3 (da)	2001-12-10

Family

ID=13479165

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK95302409T DK0676398T3 (da)	1994-04-11	1995-04-11	Heterocykliske forbindelser, som har antidiabetisk aktivitet, deres fremstilling og deres anvendelse
DK00102313T DK1022274T3 (da)	1994-04-11	1995-04-11	Mellemprodukter til fremstillingen af oxazolidindion og thiazolidindion derivater

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK00102313T DK1022274T3 (da)	1994-04-11	1995-04-11	Mellemprodukter til fremstillingen af oxazolidindion og thiazolidindion derivater

Country Status (21)

Country	Link
US (6)	US5624935A (da)
EP (2)	EP0676398B1 (da)
KR (1)	KR950032188A (da)
CN (1)	CN1060173C (da)
AT (2)	ATE222895T1 (da)
AU (1)	AU683348B2 (da)
CA (1)	CA2146701A1 (da)
CZ (1)	CZ289317B6 (da)
DE (2)	DE69523358T2 (da)
DK (2)	DK0676398T3 (da)
ES (2)	ES2165895T3 (da)
FI (1)	FI951731A7 (da)
HU (1)	HU219887B (da)
ID (1)	ID20564A (da)
IL (1)	IL113313A (da)
NO (2)	NO305987B1 (da)
NZ (1)	NZ270917A (da)
PT (2)	PT1022274E (da)
RU (2)	RU2151145C1 (da)
TW (2)	TW407156B (da)
ZA (1)	ZA952990B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ289317B6 (cs) *	1994-04-11	2002-01-16	Sankyo Company Limited	Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
TW403748B (en) *	1994-11-02	2000-09-01	Takeda Chemical Industries Ltd	An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
US5925656A (en) *	1995-04-10	1999-07-20	Dr. Reddy's Research Foundation	Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
CZ293016B6 (cs) *	1995-06-01	2004-01-14	Sankyo Company Limited	Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5798375A (en) *	1995-07-03	1998-08-25	Sankyo Company, Limited	Treatment of arteriosclerosis and xanthoma
EP0783888A1 (en)	1995-12-26	1997-07-16	Sankyo Company Limited	Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
IL120443A (en) *	1996-03-18	2000-07-16	Sankyo Co	Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
US5919782A (en) *	1996-05-06	1999-07-06	Dr. Reddy's Research Foundation	Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889025A (en) *	1996-05-06	1999-03-30	Reddy's Research Foundation	Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) *	1996-05-06	1997-12-02	Reddy Research Foundation	Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
CA2257284C (en) *	1996-05-31	2005-10-04	Sankyo Company Limited	Remedy for autoimmune diseases
BR9711098B1 (pt)	1996-07-01	2011-10-04		compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
US6114526A (en) *	1996-07-01	2000-09-05	Dr. Reddy's Research Foundation	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en)	1996-07-01	2002-04-16	Dr. Reddy's Research Foundation	Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) *	1996-07-01	1999-03-23	Dr. Reddy's Research Foundation	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) *	1996-07-01	2006-09-05	Dr. Reddy's Laboratories, Limited	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
PL334655A1 (en) *	1997-01-23	2000-03-13	Yamanouchi Pharma Co Ltd	Novel amidic derivatives and therapeutic preparations containing them
US6011036A (en) *	1997-04-15	2000-01-04	Dr. Reddy's Research Foundation	Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them
WO1997041121A1 (en) *	1997-05-02	1997-11-06	Dr. Reddy's Research Foundation	Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
KR100666887B1 (ko)	1997-10-08	2007-01-10	상꾜 가부시키가이샤	치환 축합 복소환 화합물
HUP9902721A2 (hu) *	1997-11-25	1999-12-28	The Procter & Gamble Co.	Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
AU7109798A (en) *	1997-12-02	1998-10-30	Dr. Reddy's Research Foundation	Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypol ipidemia and antihypertensive properties
US7105552B2 (en) *	1998-05-08	2006-09-12	Theracos, Inc.	Heterocyclic analogs of diphenylethylene compounds
US7407978B2 (en) *	1999-04-06	2008-08-05	Theracos, Inc.	Heterocyclic analogs of diphenylethylene compounds
PL351878A1 (en) *	1999-04-07	2003-06-30	Sankyo Co	Amino compound derivatives
WO2000061582A1 (en) *	1999-04-08	2000-10-19	Sankyo Company, Limited	Substituted fused imidazole derivatives
IL130169A (en) *	1999-05-27	2006-08-20	Neurim Pharma 1991	Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them
CA2377246A1 (en) *	1999-06-18	2000-12-28	Ranjit C. Desai	Arylthiazolidinedione and aryloxazolidinedione derivatives
AU4116801A (en) *	2000-03-17	2001-09-24	Ajinomoto Kk	Drugs for complications of diabetes and neuropathy and utilization thereof
US6921762B2 (en) *	2001-11-16	2005-07-26	Amgen Inc.	Substituted indolizine-like compounds and methods of use
ITRM20020016A1 (it) *	2002-01-15	2003-07-15	Sigma Tau Ind Farmaceuti	Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
US7232828B2 (en)	2002-08-10	2007-06-19	Bethesda Pharmaceuticals, Inc.	PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
CA2565803A1 (en) *	2004-05-28	2006-03-02	Weiguo Liu	Benzoureas having anti-diabetic activity
CN101111266A (zh) *	2005-01-31	2008-01-23	味之素株式会社	含有降血糖药的用于改善或治疗糖耐量异常、临界性糖尿病、胰岛素抵抗性和高胰岛素血症的药物组合物
WO2006138328A1 (en) *	2005-06-14	2006-12-28	Merck & Co., Inc.	Process for the production of antidiabetic oxazolidinediones
JP2009502783A (ja) *	2005-07-20	2009-01-29	メルクエンドカムパニーインコーポレーテッド	抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン
EP2774925B1 (en)	2005-11-08	2016-12-28	Vertex Pharmaceuticals Incorporated	Heterocyclic modulators of ATP-binding cassette transporters
WO2008141119A2 (en)	2007-05-09	2008-11-20	Vertex Pharmaceuticals Incorporated	Modulators of cftr
NZ597381A (en) *	2007-09-14	2013-03-28	Metabolic Solutions Dev Co Llc	Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
US8143280B2 (en) *	2007-09-27	2012-03-27	Hoffmann-La Roche Inc.	Glucocorticoid receptor antagonists
HUE031913T2 (en)	2007-12-07	2017-08-28	Vertex Pharma	Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
PL2231606T3 (pl) *	2007-12-07	2013-07-31	Vertex Pharma	Sposoby wytwarzania kwasów cykloalkilokarboksyamidopirydynobenzoesowych
CN101463031B (zh) *	2007-12-20	2014-02-12	中国医学科学院药物研究所	吲唑及四氢吲唑类化合物及其制法和其药物组合物与用途
JP5523352B2 (ja)	2008-02-28	2014-06-18	バーテックスファーマシューティカルズインコーポレイテッド	Ｃｆｔｒ修飾因子としてのへテロアリール誘導体
UY31952A (es) *	2008-07-02	2010-01-29	Astrazeneca Ab	5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
RS62767B1 (sr)	2010-04-07	2022-01-31	Vertex Pharma	Farmaceutski sastavi 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiriodin-2-il)benzojeve kiseline i njihova primena
MX355183B (es)	2012-01-25	2018-04-09	Vertex Pharma	Formulaciones de acido 3- (6- (1- (2.2- difluorobenzo [d] [1,3] dioxol-5-il) ciclopropancarboxamido) -3- metilpiridin-2-il) benzoico.
HRP20210516T2 (hr)	2013-11-12	2021-10-01	Vertex Pharmaceuticals Incorporated	Postupak proizvodnje farmaceutskih pripravaka za liječenje bolesti koje su posredovane putem cftr
KR102576006B1 (ko)	2014-11-18	2023-09-06	버텍스 파마슈티칼스 인코포레이티드	고처리량 시험 고성능 액체 크로마토그래피의 수행 방법
CN111883832A (zh) *	2020-07-24	2020-11-03	香河昆仑化学制品有限公司	一种锂离子电池电解液以及电池负极和电化学储能器件

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4097594A (en) *	1977-03-30	1978-06-27	Fmc Corporation	Mono-5-substituted-3-chloro-4H-1,2,6-thiadiazin-4-one antifungal agents
JPS5522636A (en) *	1978-08-04	1980-02-18	Takeda Chem Ind Ltd	Thiazoliding derivative
JPS6051189A (ja) *	1983-08-30	1985-03-22	Sankyo Co Ltd	チアゾリジン誘導体およびその製造法
JPS60226873A (ja) *	1984-03-28	1985-11-12	Sankyo Co Ltd	１，３−ベンゾオキサチオ−ル誘導体及びその製法
CN1003445B (zh) *	1984-10-03	1989-03-01	武田药品工业株式会社	噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) *	1985-02-26	2000-08-07	Sankyo Co	Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) *	1985-06-10	1994-01-05	武田薬品工業株式会社	チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4681940A (en) *	1985-11-19	1987-07-21	American Home Products Corporation	5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
US4873255A (en) *	1987-02-04	1989-10-10	Sankyo Company Limited	Thiazolidinone derivatives, their preparation and their use
JPH0764866B2 (ja) *	1987-02-24	1995-07-12	財団法人微生物化学研究会	１−ｎ−（４−アミノ−３−フルオロ−２−ヒドロキシブチリル）カナマイシン類
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB8820389D0 (en) *	1988-08-26	1988-09-28	Beecham Group Plc	Novel compounds
WO1991007107A1 (en) *	1989-11-13	1991-05-30	Pfizer Inc.	Oxazolidinedione hypoglycemic agents
US5143930A (en) *	1990-02-07	1992-09-01	Sankyo Company, Limited	Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
EP0839812A1 (en) *	1990-04-27	1998-05-06	Sankyo Company Limited	Preparation of benzylthiazolidine derivatives
GB9017218D0 (en) *	1990-08-06	1990-09-19	Beecham Group Plc	Novel compounds
US5334604A (en) *	1990-08-23	1994-08-02	Pfizer Inc.	Hypoglycemic hydroxyurea derivatives
GB9023585D0 (en) *	1990-10-30	1990-12-12	Beecham Group Plc	Novel compounds
GB9023584D0 (en) *	1990-10-30	1990-12-12	Beecham Group Plc	Novel compounds
WO1992018501A1 (en) *	1991-04-11	1992-10-29	The Upjohn Company	Thiazolidinedione derivatives, production and use thereof
FR2680512B1 (fr) *	1991-08-20	1995-01-20	Adir	Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO179246C (no) *	1991-11-20	1996-09-04	Sankyo Co	Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
NO302471B1 (no) *	1991-12-26	1998-03-09	Sankyo Co	Tiazolidinforbindelser og farmasöytisk preparat
NO302519B1 (no) *	1991-12-26	1998-03-16	Sankyo Co	Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
EP0590793B1 (en) *	1992-08-31	1999-10-13	Sankyo Company Limited	Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
US5614544A (en) *	1993-09-14	1997-03-25	Takeda Chemical Industries, Ltd.	Oxazolidinedione derivatives and their use
CZ289317B6 (cs) *	1994-04-11	2002-01-16	Sankyo Company Limited	Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití

1995
- 1995-04-10 CZ CZ1995910A patent/CZ289317B6/cs not_active IP Right Cessation
- 1995-04-10 RU RU95118736/04A patent/RU2151145C1/ru not_active IP Right Cessation
- 1995-04-10 CA CA002146701A patent/CA2146701A1/en not_active Abandoned
- 1995-04-10 NO NO951398A patent/NO305987B1/no not_active IP Right Cessation
- 1995-04-10 RU RU95105423/04A patent/RU2114844C1/ru not_active IP Right Cessation
- 1995-04-10 IL IL11331395A patent/IL113313A/xx not_active IP Right Cessation
- 1995-04-11 PT PT00102313T patent/PT1022274E/pt unknown
- 1995-04-11 AU AU16383/95A patent/AU683348B2/en not_active Ceased
- 1995-04-11 AT AT00102313T patent/ATE222895T1/de not_active IP Right Cessation
- 1995-04-11 DE DE69523358T patent/DE69523358T2/de not_active Expired - Fee Related
- 1995-04-11 ZA ZA952990A patent/ZA952990B/xx unknown
- 1995-04-11 CN CN95105765A patent/CN1060173C/zh not_active Expired - Fee Related
- 1995-04-11 PT PT95302409T patent/PT676398E/pt unknown
- 1995-04-11 EP EP95302409A patent/EP0676398B1/en not_active Expired - Lifetime
- 1995-04-11 ES ES95302409T patent/ES2165895T3/es not_active Expired - Lifetime
- 1995-04-11 TW TW084103469A patent/TW407156B/zh not_active IP Right Cessation
- 1995-04-11 DE DE69528000T patent/DE69528000T2/de not_active Expired - Fee Related
- 1995-04-11 HU HU9501040A patent/HU219887B/hu not_active IP Right Cessation
- 1995-04-11 ES ES00102313T patent/ES2180477T3/es not_active Expired - Lifetime
- 1995-04-11 NZ NZ270917A patent/NZ270917A/en unknown
- 1995-04-11 TW TW087114283A patent/TW503237B/zh not_active IP Right Cessation
- 1995-04-11 DK DK95302409T patent/DK0676398T3/da active
- 1995-04-11 US US08/419,919 patent/US5624935A/en not_active Expired - Fee Related
- 1995-04-11 DK DK00102313T patent/DK1022274T3/da active
- 1995-04-11 EP EP00102313A patent/EP1022274B1/en not_active Expired - Lifetime
- 1995-04-11 ID IDP981611A patent/ID20564A/id unknown
- 1995-04-11 KR KR1019950008429A patent/KR950032188A/ko not_active Abandoned
- 1995-04-11 FI FI951731A patent/FI951731A7/fi unknown
- 1995-04-11 AT AT95302409T patent/ATE207488T1/de not_active IP Right Cessation
1996
- 1996-09-13 US US08/713,543 patent/US5834501A/en not_active Expired - Fee Related
- 1996-11-08 US US08/745,377 patent/US5739345A/en not_active Expired - Fee Related
1997
- 1997-12-30 US US09/001,093 patent/US5962470A/en not_active Expired - Fee Related
1998
- 1998-07-07 US US09/110,693 patent/US5977365A/en not_active Expired - Fee Related
- 1998-08-25 NO NO983900A patent/NO307299B1/no not_active IP Right Cessation
1999
- 1999-03-03 US US09/261,645 patent/US6117893A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ZA952990B (en)	1995-12-21
DE69523358T2 (de)	2002-07-11
EP0676398A3 (en)	1998-07-01
DE69523358D1 (de)	2001-11-29
US5962470A (en)	1999-10-05
DE69528000D1 (de)	2002-10-02
HU219887B (hu)	2001-08-28
TW407156B (en)	2000-10-01
ES2165895T3 (es)	2002-04-01
RU95105423A (ru)	1997-03-20
NO951398L (no)	1995-10-12
CZ91095A3 (en)	1997-12-17
DE69528000T2 (de)	2003-05-28
HU9501040D0 (en)	1995-06-28
EP0676398B1 (en)	2001-10-24
FI951731L (fi)	1995-10-12
CN1118781A (zh)	1996-03-20
AU1638395A (en)	1995-10-19
DK1022274T3 (da)	2002-10-28
ATE222895T1 (de)	2002-09-15
NZ270917A (en)	1996-12-20
PT1022274E (pt)	2002-11-29
FI951731A0 (fi)	1995-04-11
IL113313A0 (en)	1995-07-31
HUT73765A (en)	1996-09-30
NO305987B1 (no)	1999-08-30
ES2180477T3 (es)	2003-02-16
EP0676398A2 (en)	1995-10-11
RU2151145C1 (ru)	2000-06-20
EP1022274B1 (en)	2002-08-28
RU2114844C1 (ru)	1998-07-10
HK1011365A1 (en)	1999-07-09
ID20564A (id)	1999-01-14
NO983900L (no)	1995-10-12
PT676398E (pt)	2002-03-28
AU683348B2 (en)	1997-11-06
CZ289317B6 (cs)	2002-01-16
NO307299B1 (no)	2000-03-13
US5739345A (en)	1998-04-14
EP1022274A1 (en)	2000-07-26
HK1029338A1 (en)	2001-03-30
ATE207488T1 (de)	2001-11-15
CA2146701A1 (en)	1995-10-12
KR950032188A (ko)	1995-12-20
IL113313A (en)	1999-09-22
US5834501A (en)	1998-11-10
US5977365A (en)	1999-11-02
NO983900D0 (no)	1998-08-25
NO951398D0 (no)	1995-04-10
TW503237B (en)	2002-09-21
CN1060173C (zh)	2001-01-03
US5624935A (en)	1997-04-29
US6117893A (en)	2000-09-12
FI951731A7 (fi)	1995-10-12

Publication	Publication Date	Title
NO951398L (no)	1995-10-12	Heterosykliske forbindelser med antidiabetisk aktivitet, deres fremstilling og anvendelse
NO953305D0 (no)	1995-08-23	Antranilsyrederivat
LU91210I2 (fr)	2006-11-06	Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
NO902214D0 (no)	1990-05-18	Fremgangsmaate for fremstilling av n-(aryloksyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner og deres anvendelse som medikamenter.
DE69717970D1 (de)	2003-01-30	Chinolin carbonsaure-derivate und ihre salze
DK0508687T3 (da)	1996-02-05	ATP-analoger
RU95118736A (ru)	1997-09-20	Промежуточное соединение для получения гетероциклических соединений, обладающих антидиабетической активностью
ATE150964T1 (de)	1997-04-15	Restenosehemmer nach perkutaner koronarer arterioplastie
DK0508740T3 (da)	1997-10-20	Thiazolidindionderivater, deres fremstilling og anvendelse.
IL146968A0 (en)	2002-08-14	Benzamide derivatives, insecticides fro agricultural and horticultural use and usage thereof
DK0547231T3 (da)	1996-09-16	Phospholipase-A2-inhibitor
NO921282L (no)	1992-10-05	Benzotiazolderivater og deres anvendelse
HU9602534D0 (en)	1996-11-28	Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
ATE105565T1 (de)	1994-05-15	Pradimicinderivate.
DK0579169T3 (da)	1999-05-31	Alkylendiaminderivater
SE9402596L (sv)	1995-01-31	Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
ATE143591T1 (de)	1996-10-15	Verwendung von bis-(p- hydroxyphenylthio)methanderivaten zur hemmung der fortschreitenden entwicklung von insulinabhängingem diabetes mellitus